NEUROPATHIC PAIN-AN ENERVATING DISEASE

Nischal Tyagi, Vineeta Tripathi, Preeti Vishwakarama, Radha Goel*

NEUROPATHIC PAIN-AN ENERVATING DISEASE

Nischal Tyagi, Vineeta Tripathi, Preeti Vishwakarama, Radha Goel*

Abstract

Neuropathic pain is a chronic pain that worsens the quality of life of the patient occurring as a result of peripheral or central nerve injury. It is characterized by spontaneous ongoing and evoked increased pain sensation upon contact with noxious or non-noxious stimuli. The management of neuropathic pain involves interdisciplinary approach and mainly focuses on pharmacological treatment. The drugs found effective in management of neuropathic pain are antiepileptics, antidepressants, opioid analgesics, NSAID’S (Non-Steroidal Anti Inflammatory Drugs), local anesthetics. Combination therapy is generally required in patients with severe neuropathic pain.

Keywords

Antidepressants, Antiepileptic, Local anesthetics, NSAID’S, Neuropathic pain, Opioid analgesics

Full Text:

PDF

References

Scadding J, Neuropathic pain review, Adv Clin Neurosci and Rehab, 2003, 3, 8-14.

Dworkin RH , Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennet, Advances in neuropathic pain, Diagnosis mechanisms and treatment recommendations, Arch neurology, 2003,60,1524- 1534.

Meena S , Kumar A, Chauhan S, Possible involvement of nitric oxide mechanism in the protective effect of Melatonin against sciatic nerve ligation induced behavioral and biochemical alterations in rats, Int J Drug Devlop and Res, 2011, 3, 224-233.

Pasero C, Pathophysiology of neuropathic pain, Pain Mgmt and Nursing, 2004, 5, 3-8.

Schwartzman JR, Kirsten LE, Guillermo MA, The natural history of complex regional pain syndrome, Clin J Pain,2009,25,273-280.

Brill V, Treatments for diabetic neuropathy, J Peripheral Nervous Sys, 2007, 17, 22–27.

Wilson JK, Sevier TL, A review of treatment for carpal tunnel syndrome, Disability and Rehab, 2003, 25, 113- 119.

Nurmikko TJ, Eldrige PR, Trigeminal neuralgia- Pathophysiology, Diagnosis and Current Treatment, British J Anesthesia , 2001, 87(1),117-132.

Chahine L, Kanazi G, phantom limb syndrome: a review, Middle East J of Anesth, 2007, 19(2), 1-12.

Ballantyne JC, Painful HIV-Associated Sensory Neuropathy, International Association for the Study of Pain, 2010, 18,647-654.

Chen PP, Josephine WY IP, Joseph MKL, Vincent M, Tsoi TH, Wong CP, Wong HSS, Recommendations for the Management of Central Post-stroke Pain, Medical Prog, 2009, 5-9.

Dal PGJ, Glass JD, McArthur JC, Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study. Neurology 1994; 44, 2159-2164.

Ford B, Pain in Parkinson’s disease, Movement Disorders, 2010, 25, S98–S103.

Attal N, Mazaltarine G, Perrouin-Verbe B, Albert T, Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration, Annals physical and Rehab Medicine, 2009, 52, 124- 141.

Sarder AH, Kamal SM, Biswas GS, Islam MS, Bakar MA, Bang, Syringomyelia with atypical presentation, Med J, 2010, 43, 21-23.

Sherry W, Debra B, Lisa K, Axel G, Charles l, Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies, Euro J Cancer 2008, 44, 1 5 0 7 –1 5 1 5.

Martin AL, Hagen AN, Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies, J Pain and Symptom Mgmt, 1997, 14, 99-117.

Nickel TF, Seifert F, Stefan L, Maihöfner C, Mechanisms of neuropathic pain, European Neuropsychopharmacol, 2012, 22, 81-91.

Garrone B, Polenzani L, Santi De S, Moreci W, Guglilemotti A, Paracetamol reduces neuropathic pain like – behavior in rats by potentiating serotonergic neurotransmission, Int J of Integrative Biol,2007,1,196-205.

Baron R, Binder A, Wasner G, Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment, 2010, 9, 807-819.

Dowrkin RH, O’ conner AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser DJ, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice ASC, Stacey BR, Treede RD, Turk DC, Wallace MS, Pharmacologic management of neuropathic pain, Evidence–Based recommendations,Pain,2007,132,237-251.

Yuan RY, Sheu JJ, Yu JM, Chen WT, Tseng IJ, Chang HH, Hu CJ, Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 2009, 72, 1473-1478.

Rowbotham MC, Rachel DW, Thomas J, Nothaft W, Backonja MM, A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. Pain 2009, 146:245-252.